XORTX Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
XORTX Therapeutics has a total shareholder equity of $2.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.9M and $1.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.30m |
| Equity | US$2.13m |
| Total liabilities | US$1.72m |
| Total assets | US$3.85m |
Recent financial health updates
Recent updates
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation
Aug 23
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business
Apr 01We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow
Dec 16Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth
Sep 01Financial Position Analysis
Short Term Liabilities: XRTX's short term assets ($2.4M) exceed its short term liabilities ($326.3K).
Long Term Liabilities: XRTX's short term assets ($2.4M) exceed its long term liabilities ($1.4M).
Debt to Equity History and Analysis
Debt Level: XRTX is debt free.
Reducing Debt: XRTX currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XRTX has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: XRTX is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.